Web27 May 2024 · A new analysis leveraging data from more than 75,000 patients with diabetic kidney disease provides evidence that could put concern over the risk of fracture with … WebThe UK Kidney Association Clinical Practice Guideline Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease has now been published. "SGLT-2 …
Renal Protection with SGLT2 Inhibitors: Effects in Acute and …
Web1 Jun 2024 · For people with type 2 diabetes and CKD with an eGFR 30 mL per minute per 1.73 m 2 or higher, metformin and sodium-glucose cotransporter 2 (SGLT2) inhibitors, in … Web13 Apr 2024 · The EMPA-KIDNEY trial (NCT03594110) is a study investigating the effect of empagliflozin on kidney disease progression or cardiovascular death compared to a placebo in patients with pre-existing chronic kidney disease . At present, the trial was terminated … cac web access
AI-Enabled KidneyIntelX Monitors SGLT2 Inhibitor …
Web25 Aug 2024 · This guideline covers care and treatment for people with, or at risk of, chronic kidney disease (CKD). It aims to prevent or delay the progression, and reduce the risk of … Web29 Jun 2024 · Research from the American Diabetes Association’s 81st Scientific Sessions suggests an AI-enabled diagnostic could allow clinicians to monitor patient response to … Web5 May 2024 · SGLT2 inhibitors have emerged as a key disease-modifying therapy to prevent the progression of chronic kidney disease (CKD). These agents prevent decline in kidney … cacw chicago